20 September 2025
: Case report 
Pediatric Liver Transplant Complications: EBV-Associated Tumors and Infection Management Strategies
Rare coexistence of disease or pathology
Li-Na Wu ABCDEF 1,2,3,4, Zhi-Gui Zeng BDE 2,3,4,5, Jing-Yi Liu
CDE 1,6,3,4, Lin Wei BD 6,3,4,5, Yu-Le Tan B 6,3,4,5, Fu-Xiao Xie CD 6,3,4,5, Zhi-Jun Zhu AF 6,3,4,5*, Li-Ying Sun A 1,6,3,7
DOI: 10.12659/AJCR.948566
Am J Case Rep 2025; 26:e948566
Figure 1 EBV-SMT in liver of PET-CT: (A) At 30.9 mo after LT, low-intensity nodule in segment 3 of transplanted liver, measuring approximately 0.9×0.6 cm. Increased FDG uptake with an SUVmax of 1.3. (B) At 34.6 mo after LT, low-intensity nodule in segment 3 of transplanted liver, measuring approximately 1.3×1.3 cm. Increased FDG uptake with an SUVmax of 1.6. (C) At 38.6 mo after LT, low-intensity nodule in segment 3 of the transplanted liver, measuring approximately 1.3×1.3 cm. Increased FDG uptake with a maximum standardized uptake value (SUVmax) of 2.8.